CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Henan Topfond Pharmaceutical Co., Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Henan Topfond Pharmaceutical Co., Ltd
2 Guangming Road
Zhumadian
Phone: +86 3963836688p:+86 3963836688 Henan, 463003  China Fax: +86 3963815761f:+86 3963815761

This company was Merged or Acquired on 8/15/2012.
This is a Subsidiary, click here for the Parent Company

Business Summary
Henan Topfond Pharmaceutical Co., Ltd. is a China-based company principally engaged in pharmaceutical manufacturing and wholesaling. It manufactures and distributes pharmaceutical raw materials and preparations. The Company’ products include tablets, capsules and injections, among others. The Company provides anti-infective drugs, drugs for acquired immune deficiency syndrome (AIDs) treatment, bulk drugs and intermediate pharmaceuticals, cardiovascular system products, prostate disease treatment products, diabetes treatment drugs, osteoporosis treatment drugs, verruca acuminata treatment drugs, alopecia treatment drugs, anaphylactic disease treatment drugs, and over-the-counter (OTC) drugs. It also produces beverage products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201312/31/2012Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board DamingNian 51 10/23/2008
Vice Chairman of the Board YincongYan 53 10/23/2008
Chief Financial Officer HuagangZhang 59 3/23/2009 3/23/2009
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 4,434 (As of 12/31/2012)
Outstanding Shares: 420,000,000 (As of 3/31/2013)
Shareholders: 36,096
Stock Exchange: SHA
Fax Number: +86 3963815761


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023